News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
355,054 Results
Type
Article (22089)
Company Profile (310)
Press Release (332655)
Section
Business (107649)
Career Advice (1466)
Deals (17406)
Drug Delivery (59)
Drug Development (58593)
Employer Resources (103)
FDA (8008)
Job Trends (7773)
News (188950)
Policy (14523)
Tag
Academia (1448)
Alliances (26669)
Alzheimer's disease (971)
Approvals (8003)
Artificial intelligence (155)
Bankruptcy (136)
Best Places to Work (6691)
Biotechnology (249)
Breast cancer (184)
Cancer (1432)
Cardiovascular disease (107)
Career advice (1226)
CAR-T (105)
Cell therapy (319)
Clinical research (47395)
Collaboration (561)
Compensation (277)
COVID-19 (1517)
C-suite (140)
Data (1397)
Diabetes (154)
Diagnostics (2635)
Earnings (42716)
Events (59046)
Executive appointments (468)
FDA (8686)
Funding (540)
Gene therapy (227)
GLP-1 (470)
Government (2003)
Healthcare (9750)
Infectious disease (1594)
Inflammatory bowel disease (115)
Interviews (254)
IPO (9520)
Job creations (1526)
Job search strategy (1033)
Layoffs (281)
Legal (2266)
Lung cancer (209)
Manufacturing (162)
Medical device (5335)
Medtech (5336)
Mergers & acquisitions (8240)
Metabolic disorders (429)
Neuroscience (1336)
NextGen: Class of 2025 (3371)
Non-profit (1993)
Northern California (1689)
Obesity (229)
Opinion (176)
Parkinson's disease (102)
Patents (108)
People (32528)
Phase I (15935)
Phase II (21431)
Phase III (14836)
Pipeline (610)
Postmarket research (1315)
Preclinical (6515)
Radiopharmaceuticals (225)
Rare diseases (291)
Real estate (2514)
Regulatory (11402)
Research institute (1373)
Resumes & cover letters (245)
Series A (103)
Southern California (1462)
Startups (2806)
United States (13780)
Vaccines (354)
Weight loss (149)
Date
Last 7 days (487)
Last 30 days (1962)
Last 365 days (25921)
2025 (3624)
2024 (25778)
2023 (27356)
2022 (33175)
2021 (34708)
2020 (31173)
2019 (24308)
2018 (17840)
2017 (18600)
2016 (16784)
2015 (19659)
2014 (14312)
2013 (10586)
2012 (10926)
2011 (11116)
2010 (10141)
Location
Africa (403)
Asia (23902)
Australia (3882)
California (3890)
Canada (1178)
China (322)
Colorado (156)
Connecticut (195)
Delaware (98)
Europe (51673)
Florida (467)
Georgia (116)
Illinois (297)
Indiana (147)
Maryland (524)
Massachusetts (2944)
Michigan (104)
Minnesota (194)
New Jersey (1013)
New York (1058)
North Carolina (575)
Northern California (1689)
Ohio (122)
Pennsylvania (753)
South America (503)
Southern California (1462)
Texas (485)
Washington State (347)
355,054 Results for "f star therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Star Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 2, 2025
·
1 min read
Press Releases
Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD)
January 7, 2025
·
2 min read
Press Releases
PESG Report: Silexion Therapeutics’ Systemic Delivery Breakthrough Positions Company as Rising Star in The Multi-Billion Dollar Precision Oncology Market
January 29, 2025
·
3 min read
Biotech Bay
Star Therapeutics Presents Clinical Data for VGA039, a Subcutaneous Therapy for the Treatment of Von Willebrand Disease (VWD)
Star Therapeutics today announced the presentation of clinical data from VIVID 1 (VGA039 Investigation in Von Willebrand Disease), a Phase 1 clinical study of VGA039 in healthy volunteers.
June 26, 2024
·
4 min read
Press Releases
Astria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0310, a Potential Best-in-Class Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis
January 23, 2025
·
7 min read
Press Releases
Star Therapeutics Presents Interim Clinical Data for VGA039 in Patients with Von Willebrand Disease (VWD) at ASH 2024
December 9, 2024
·
6 min read
Press Releases
Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0310, a Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis
December 10, 2024
·
6 min read
Deals
invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
InvoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline of innovative products, today announces that it has successfully completed the acquisition of F-star Therapeutics, Inc. (“F-star”) (NASDAQ:FSTX).
March 8, 2023
·
6 min read
Business
F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies
F-star Therapeutics , an invoX company (“F-star”) , today announced that it has entered into a strategic discovery collaboration and licence agreement with Takeda.
July 5, 2023
·
4 min read
Press Releases
Astria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAE
December 11, 2024
·
10 min read
1 of 35,506
Next
